In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating ...

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025.Fourth positive DSMB ...

M&T Bank Corp lifted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 23.4% in the fourth ...

Morgan Stanley assumed coverage of Neurocrine (NBIX) with an Overweight rating and a price target of $150, down from $185. The firm sees ...

Neurocrine Biosciences (NasdaqGS:NBIX) announced the initiation of a Phase 1 clinical study for the compound NBI-1140675, a new VMAT2 inhibitor. This development could influence investor sentiment, ...

Neurocrine Biosciences, Inc. today announced the initiation of a Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of investigational compound ...

In recent years, Neurocrine has concentrated on expanding its research and development (R&D) capabilities and enhancing its product portfolio. This is evident from the significant investment in ...

February was a great testing month for me; i.e. the majority of the beauty products that passed through these hands were good if not impressive. Though that is objectively good news it means that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Compounded medications are customized or altered to meet a specific need (in this case, mixing two active ingredients into one topical product). While compounded medications like this one use ...

We rounded up the best hair growth products below. Hair loss affects many people. The most common cause is hereditary hair loss, called androgenic alopecia. Around 40% of females and 50% of males ...